XiaoMi recently just announced that it’ll launch it’s line of phones in Malaysia starting with the company’s much anticipated Mi3 which is on sale now for RM 889 (US$280) well under the price of other manufacturer’s flagships. The fledgling manufacturer is now adding more hardware to its already impressive arsenal of devices – the XiaoMi MiPad.
The XiaoMi MiPad will be the first device to tout NVIDIA’s brand new Tegra K1, successor of the Tegra 4, which wasn’t that successful after the disappointing Tegra 3. NVIDIA’s Tegra K1 benchmarks put the processor well above the current generation Snapdragon Processors, at least on paper. But NVIDIA’s bold move to scrap its previous development plans in favor of the current Tegra K1 which mirrors the development of it’s wildly successful desktop processors has yet to attract any manufacturers, not even HTC, which used the previous NVIDIA Tegra 3 in its flagship HTC One X in 2012.
There’s no hiding the design cues in this tablet. It is heavily, and I mean HEAVILY, influenced by Apple’s Ipad Air. As noted by other blogs, the design language of the XiaoMi MiPad seems to “borrow” heavily from that of the iPad air which could be dangerous, especially given Apple’s tendency to compete in the courts rather than in the market.
However, that aside, the XiaoMi MiPad is definitely impressive, the performance of the MiPad is bound to be astounding, if the benchmarks of the quad-core Tegra K1 are any indication. The MiPad comes with 7.9-inch 2048×1536 IPS display withtwo storage variants – 16GB and 64GB – both expandable with microSD storage. The tablet also comes with 2GB of RAM and an 8-megapixel back camera and a meaty 5-megapixel front facing “selfie cam”. All of this runs on a 6700mAh battery on Android 4.4 KitKat with its proprietary MIUI skin with WiFi and bluetooth connectivity, no word yet on cellular connectivity with the XiaoMi MiPad.
The XiaoMi MiPad is going to be available in four colours at the price point of CN¥1499 (RM 775) for the 16GB and ¥1699 (RM 880) for the 64GB option. However, aside from the beta in China, there is no confirmation on the availability of the tablet in the worldwide market as of yet.